Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Mendelian randomization of blood lipids for coronary heart disease

Open access

Abstract

AIMS: To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization. METHODS AND RESULTS: We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a prior meta-analysis (threshold P < 2 × 10(-6)); and the second a restricted score, filtered to remove any SNPs also associated with either of the other two lipid traits at P ≤ 0.01. Mendelian randomization meta-analyses were conducted in 17 studies including 62,199 participants and 12,099 CHD events. Both the unrestricted and restricted allele scores for LDL-C (42 and 19 SNPs, respectively) associated with CHD. For HDL-C, the unrestricted allele score (48 SNPs) was associated with CHD (OR: 0.53; 95% CI: 0.40, 0.70), per 1 mmol/L higher HDL-C, but neither the restricted allele score (19 SNPs; OR: 0.91; 95% CI: 0.42, 1.98) nor the unrestricted HDL-C allele score adjusted for triglycerides, LDL-C, or statin use (OR: 0.81; 95% CI: 0.44, 1.46) showed a robust association. For triglycerides, the unrestricted allele score (67 SNPs) and the restricted allele score (27 SNPs) were both associated with CHD (OR: 1.62; 95% CI: 1.24, 2.11 and 1.61; 95% CI: 1.00, 2.59, respectively) per 1-log unit increment. However, the unrestricted triglyceride score adjusted for HDL-C, LDL-C, and statin use gave an OR for CHD of 1.01 (95% CI: 0.59, 1.75). CONCLUSION: The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/eht571

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Meta-analysis pooled estimates of the association of the unrestricted and restricted allele scores with target and non-target lipid traits. Estimates were obtained from prospective cohorts genotyped using the ITMAT Broad Institute CARe consortium CardioChip array (detailed in Supplementary material online, Table S1). A lower limit of 0 was imposed on the R2 values. Mean diff, mean difference comparing top to bottom quintile of each allele score. R2 = proportion of variable of the lipid traits explained by each allele score. TG, triglycerides.
Figure 1 Meta-analysis pooled estimates of the association of the unrestricted and restricted allele scores with target and non-target lipid traits. Estimates were obtained from prospective cohorts genotyped using the ITMAT Broad Institute CARe consortium CardioChip array (detailed in Supplementary material online, Table S1). A lower limit of 0 was imposed on the R2 values. Mean diff, mean difference comparing top to bottom quintile of each allele score. R2 = proportion of variable of the lipid traits explained by each allele score. TG, triglycerides.CC BY-NC · PubMed Central
Figure 2 Meta-analysis pooled estimates for the effect of a 1 unit increase in blood lipid traits on coronary heart disease risk using instrumental variable analysis incorporating data from all studies. Estimates were derived incorporating data on the association between the allele scores and blood lipid traits only from prospective cohorts (in which most individuals were free from disease when lipid traits were measured) and applying this estimate to all studies with data on the association between the scores and coronary heart disease (including case–control studies). See Methods for further details. TG, triglycerides.
Figure 2 Meta-analysis pooled estimates for the effect of a 1 unit increase in blood lipid traits on coronary heart disease risk using instrumental variable analysis incorporating data from all studies. Estimates were derived incorporating data on the association between the allele scores and blood lipid traits only from prospective cohorts (in which most individuals were free from disease when lipid traits were measured) and applying this estimate to all studies with data on the association between the scores and coronary heart disease (including case–control studies). See Methods for further details. TG, triglycerides.CC BY-NC · PubMed Central
Figure 3 Meta-analysis pooled estimates for the effect of a 1 unit increase in blood lipid traits on combined incident/prevalent coronary heart disease risk using instrumental variable analysis with the unrestricted allele score, adjusted for non-target traits and statin use. Analysis was conducted in prospective cohorts with instrumental variables regression analysis. TG, triglycerides.
Figure 3 Meta-analysis pooled estimates for the effect of a 1 unit increase in blood lipid traits on combined incident/prevalent coronary heart disease risk using instrumental variable analysis with the unrestricted allele score, adjusted for non-target traits and statin use. Analysis was conducted in prospective cohorts with instrumental variables regression analysis. TG, triglycerides.CC BY-NC · PubMed Central
Figure 4 Meta-analysis pooled estimate for the effect of a 1 unit increase in blood lipid traits on carotid intima medial thickness. The four population-based prospective cohorts with carotid intima medial thickness traits were CHS, FHS, MESA, and Whitehall II (Supplementary material online, Table S4).
Figure 4 Meta-analysis pooled estimate for the effect of a 1 unit increase in blood lipid traits on carotid intima medial thickness. The four population-based prospective cohorts with carotid intima medial thickness traits were CHS, FHS, MESA, and Whitehall II (Supplementary material online, Table S4).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 808

Metadata

Authors
Holmes, M. V., Asselbergs, F. W., Palmer, T. M., Drenos, F., Lanktree, M. B., Nelson, C. P., Dale, C. E., Padmanabhan, S., Finan, C., Swerdlow, D. I., Tragante, V., van Iperen, E. P. A., Sivapalaratnam, S., Shah, S., Elbers, C. C., Shah, T., Engmann, J., Giambartolomei, C., White, J., Zabaneh, D., Sofat, R., McLachlan, S., on behalf of the UCLEB consortium, Doevendans, P. A., Balmforth, A. J., Hall, A. S., North, K. E., Almoguera, B., Hoogeveen, R. C., Cushman, M., Fornage, M., Patel, S. R., Redline, S., Siscovick, D. S., Tsai, M. Y., Karczewski, K. J., Hofker, M. H., Verschuren, W. M., Bots, M. L., van der Schouw, Y. T., Melander, O., Dominiczak, A. F., Morris, R., Ben-Shlomo, Y., Price, J., Kumari, M., Baumert, J., Peters, A., Thorand, B., Koenig, W., Gaunt, T. R., Humphries, S. E., Clarke, R., Watkins, H., Farrall, M., Wilson, J. G., Rich, S. S., de Bakker, P. I. W., Lange, L. A., Davey Smith, G., Reiner, A. P., Talmud, P. J., Kivimäki, M., Lawlor, D. A., Dudbridge, F., Samani, N. J., Keating, B. J., Hingorani, A. D., & Casas, J. P.
Affiliations
  • University College London (GB)
  • University Medical Center Utrecht (NL)
  • University of Warwick (GB)
  • University of Bristol (GB)
  • McMaster University (CA)
  • University of Leicester (GB)
  • London School of Hygiene & Tropical Medicine (GB)
  • University of Glasgow (GB)
  • Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, Utrecht, The Netherlands
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Children's Hospital of Philadelphia (US)
  • University of Edinburgh (GB)
  • University of Leeds (GB)
  • University of North Carolina at Chapel Hill (US)
  • Baylor College of Medicine (US)
  • University of Vermont (US)
  • The University of Texas Health Science Center at Houston (US)
  • Brigham and Women's Hospital (US)
  • University of Washington (US)
  • University of Minnesota (US)
  • Stanford Medicine (US)
  • University Medical Center Groningen (NL)
  • National Institute for Public Health and the Environment (NL)
  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
  • Lund University (SE)
  • The Royal Free Hospital (GB)
  • School of Social and Community Medicine, University of Bristol
  • Genetic Epidemiology Group, Institute of Cardiovacular Science, Faculty of Population Healh Sciences, University College London, 1–19 Torrington Place, London WC1E 6BT, UK
  • Helmholtz Munich (DE)
  • Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany
  • University of Oxford (GB)
  • University of Mississippi Medical Center (US)
  • University of Virginia (US)
  • Department of Medical Genetics, Division of Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands
  • MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK
  • Fred Hutch Cancer Center (US)
  • Department of Epidemiology and Public Health, University College London, 1–19 Torrington Place, London WC1E 6BT, UK
Corresponding author
Holmes, Michael V.
Venue
European Heart Journal
Published
2014-01-28
Volume
36
Issue
9
Pages
539-550
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2159738130
Cited by
748
References
36
Citations by year
2026: 35 · 2025: 58 · 2024: 69 · 2023: 63 · 2022: 67 · 2021: 94 · 2020: 77 · 2019: 66 · 2018: 53 · 2017: 58 · 2016: 55 · 2015: 32 · 2014: 18
FWCI
7.20
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • European Heart Journal (publishedVersion, other-oa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Bristol Research (University of Bristol) (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • UniSA Research Outputs Repository (University of South Australia) (acceptedVersion, cc-by-nc)
  • Open Access at Essex (University of Essex) (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Brunel University Research Archive (BURA) (Brunel University London) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Lancaster EPrints (Lancaster University) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
  • Lund University Publications (Lund University) (submittedVersion, other-oa)
  • Site cant be reached (submittedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
  • UNC Libraries
Funders
  • U.S. Department of Health and Human Services (42129‐32, 42107-26, 32108‐9, 32118-32119, 32115, 32111‐13, 32100‐2, 44221, 32105‐6, 32122, 24152)
  • AstraZeneca
  • GlaxoSmithKline
  • Queen Mary University of London
  • London School of Hygiene and Tropical Medicine
  • Wellcome Trust (090532, 090532/Z/09/Z, 090532/Z/09/)
  • Government of the United Kingdom
  • National Institute for Health and Care Research
  • British Heart Foundation (LSHM-CT-2007-037273, G0802432, 090532/Z/09/Z, CH98001, RG/13/16/30528, PG/07/133/24260, RG/08/008/25291, BHF RG 08/008, PG/07/133/24260, RG/07/005, RG 08/008, RG/10/12/28456, RG/07/005/23633, PG/13/66/30442, RG/13/2/30098, PG/07/131/24254)
  • Research Councils UK
  • University College London
  • European Commission (LSHM-CT-2007–037273)
  • Rosetrees Trust
  • University of Bristol
  • European Foundation for the Study of Diabetes
  • Deutsche Forschungsgemeinschaft (TH-784/2–2)
  • ZonMw
  • Academy of Finland
  • Bundesministerium für Bildung und Forschung (01GS0834)
  • Hjärt-Lungfonden (RG/10/12/28456)
  • Karolinska Institutet
  • Knut och Alice Wallenbergs Stiftelse
  • Stockholms Läns Landsting (560183)
  • Universitetet i Oslo
  • Universität Ulm
  • National Institutes of Health (n01wh32105-27-0-1, n01hc95164-17-0-1, n01wh32108-30-0-1, n01wh32100-28-0-1, n01hc55021-47-0-1, n01wh32118-27-0-1, 32122, n01hc95165-34-0-1, n01hc55020-39-0-0, 32111‐13, n01hc55016-37-0-0, n01hc055022-024, n01hc95161-24-0-1, 32108‐9, 42129‐32, n01hc095169-003, NHLBI 33014, n01wh44221-7-0-1, 42107–26, n01wh42129-23-0-1, n01hc65226-6-0-0, n01hc95166-21-0-1, n01wh32111-28-0-1, n01wh32115-26-0-1, N01 WH 44221, n01wh22110-38-0-0, N01-WH-3-2115, n01hc95162-31-0-1, N01WH24152, 32118-32119, n01hc55019-35-0-1, 44221, 32115, n01hc95168-27-0-1, 32100‐2, n01hc95160-18-0-1, n01hc095167-000, n01wh24152-12-0-0, n01hc55018-38-0-1, n01hc95163-22-0-1, n01wh32122-31-0-1, N01-WH-3-2122, n01wh42107-22-0-1, n01hc95159-40-0-1, 23633, 24152, N01WH42129-32, N01-WH-32108-9, N01WH 32111-13, N01 WH 32105-6, N01 WH022110, N01-WH-32100-2, N01-WH-42107-26, N01WH 32118-32119, n01hc55015-48-0-1, 32105-6)
  • U.S. Public Health Service (HHSN268200960009C, 33014)
  • Medical Research Council (MR/K013351/1, MR/K006584/1, RG/10/12/28456, MR/L01629X/1, MR/K006215/1, WC1E 6BT, G0802432)
  • Economic and Social Research Council (ES/J023299/1)
  • World Cancer Research Fund
  • Agentschap NL (grant IGE05012, IGE05012)
  • Sahlgrenska Akademin
  • Münchner Zentrum für Gesundheitswissenschaften
  • National Institute on Aging (R01 AG1764406 S1, RG/10/12/28456, R01AG017644)
  • National Heart, Lung, and Blood Institute (33014, N01-HC55022, N01-HC-65226, N01 HC-95159, N01-HC-95160, N01 HC055016, N01-HC-55018, N01-HC095169, 32100‐2, N01 HC-95168, 32118‐32119, N01 HC95167, N01 HC 55020, (N01-HC-95163, 32118, N01 HC 55019, N01 HC-95161, N01 HC95165, N01HC95164, N01 HC055020, 42107‐26, N01-HC-095159, N01 HC055018, 32119, 24152, 32105–6, RG/10/12/28456, 32108‐9, ­N01-HC55016, 32111–13, 32115, N01 HC055022, N01 HC065226, 42129‐32, HL36310, N01 HC055019, N01‐HC‐95166, 32122, N01‐HC‐55015, N01 HC-95162, N01-HC55021, N01 HC055021, N01 HC055015, R01HL036310, 44221, N01 HC95169)
  • National Center for Research Resources (UL1RR024156, RR024156)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords
coronary artery disease, HDL cholesterol, triglycerides, LDL cholesterol, serum lipids, single nucleotide polymorphisms, instrumental variables, statin use, genetic risk factors, lipid-lowering therapy, cardiovascular risk prediction, triglyceride-lowering therapy, LDL-C lowering therapy
MeSH terms
Coronary Artery Disease, Female, Gene Frequency, Genotype, Humans, Cholesterol, HDL, Male, Middle Aged, Triglycerides, Case-Control Studies, Risk Assessment, Polymorphism, Single Nucleotide, Mendelian Randomization Analysis, Genotyping Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mendelian randomization of blood lipids for coronary heart disease. https://app.cochat.ai/papers/10.1093/eurheartj/eht571
The paper
Holmes, M. V., Asselbergs, F. W., Palmer, T. M., Drenos, F., Lanktree, M. B., Nelson, C. P., Dale, C. E., Padmanabhan, S., Finan, C., Swerdlow, D. I., Tragante, V., van Iperen, E. P. A., Sivapalaratnam, S., Shah, S., Elbers, C. C., Shah, T., Engmann, J., Giambartolomei, C., White, J., . . . Casas, J. P. (2015). Mendelian randomization of blood lipids for coronary heart disease. European Heart Journal. https://doi.org/10.1093/eurheartj/eht571

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.